Clinical trial · Observational
Biology of Osteosarcoma (BOOST) Registry and Biobank
NCT03225872CI-TRIAL-00098230BOOSTcompletedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Osteosarcoma is very rare cancer of the bone. The investigator started the BOOST registry and biobank to make sure every patient has the opportunity to participate in research.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Osteosarcoma | Osteosarcoma | ONTOLOGY_EXACT | 0.90 |
Interventions
Interventions (0)
Data not yet available
No intervention recorded.
Design
Arms and outcomes
Arms (1)
- label
- Osteosarcoma patients and family members
- description
- Osteosarcoma patients and family members
Primary outcomes (1)
- measure
- Determine if genes can determine osteosarcoma
- timeFrame
- Baseline
- description
- To do this the investigator will compare the genes of people with osteosarcoma to the genes of people who do not have these conditions.
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 0 Years
Show eligibility criteria text
Inclusion Criteria: * Proband Inclusion criteria: A diagnosis or suspected diagnosis of osteosarcoma (ICCC 9180-9200) Family member inclusion criteria: Biological parents and full biological siblings of a case diagnosed with osteosarcoma (ICCC 9180-9200) Exclusion Criteria: * Does not understand English.
References
Publications (0)
Data not yet available
No reference posted for this study.